{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Park JD"],"funding":["National Research Foundation of Korea (NRF)"],"pagination":["237"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10329652"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(1)"],"pubmed_abstract":["Triple-negative breast cancer (TNBC) is the most lethal form of breast cancer. TNBC patients have higher rates of metastasis and restricted therapy options. Although chemotherapy is the conventional treatment for TNBC, the frequent occurrence of chemoresistance significantly lowers the efficacy of treatment. Here, we demonstrated that ELK3, an oncogenic transcriptional repressor that is highly expressed in TNBC, determined the chemosensitivity of two representative TNBC cell lines (MDA-MB231 and Hs578T) to cisplatin (CDDP) by regulating mitochondrial dynamics. We observed that the knockdown of ELK3 in MDA-MB231 and Hs578T rendered these cell lines more susceptible to the effects of CDDP. We further demonstrated that the chemosensitivity of TNBC cells was caused by the CDDP-mediated acceler"],"journal":["Cell death discovery"],"pubmed_title":["The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics."],"pmcid":["PMC10329652"],"funding_grant_id":["NRF-2022R1A2C1003390"],"pubmed_authors":["Park JD","Park W","Jang HJ","Choi SH","Hwang S","Jo GH","Choi JH","Park KS"],"additional_accession":[]},"is_claimable":false,"name":"The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics.","description":"Triple-negative breast cancer (TNBC) is the most lethal form of breast cancer. TNBC patients have higher rates of metastasis and restricted therapy options. Although chemotherapy is the conventional treatment for TNBC, the frequent occurrence of chemoresistance significantly lowers the efficacy of treatment. Here, we demonstrated that ELK3, an oncogenic transcriptional repressor that is highly expressed in TNBC, determined the chemosensitivity of two representative TNBC cell lines (MDA-MB231 and Hs578T) to cisplatin (CDDP) by regulating mitochondrial dynamics. We observed that the knockdown of ELK3 in MDA-MB231 and Hs578T rendered these cell lines more susceptible to the effects of CDDP. We further demonstrated that the chemosensitivity of TNBC cells was caused by the CDDP-mediated acceler","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jul","modification":"2025-04-20T03:46:03.312Z","creation":"2025-04-20T03:46:03.312Z"},"accession":"S-EPMC10329652","cross_references":{"pubmed":["37422450"],"doi":["10.1038/s41420-023-01536-5"]}}